21173 ⎘
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA; Virus inactivated (killed)
Inactivated chikungunya viruses (CHIKV) comprising an E1-K211E mutation
#602Method for inactivating viruses with slightly acidic arginine
#603Vaccine adjuvants from self-assembling peptides
#604Compositions for canine respiratory disease complex
#605Liquid stable virus vaccines
#606Adjuvant compositions
#607Inactivated virus compositions and methods of preparing such compositions
#608Stabilizing excipient for inactivated whole virus vaccine
#609Live attenuated virus vaccines for La Crosse virus and other Bunyaviridae
#610Tissue targeted antigenic activation of the immune response to treat cancers
#611Compositions and methods for treating and preventing porcine reproductive and respiratory syndrome
#612Inactivated poliovaccine
#613Tissue targeted antigenic activation of the immune response to treat cancers
#614Reassortant BTV and AHSV vaccines
#615Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
#616Schmallenberg virus (SBV) vaccine, methods of production, and uses thereof
#617Newcastle disease virus and the use thereof as a vaccine
#618Mucosal adjuvant composition
#619Vaccines for inclusion body hepatitis
#620Human antibodies to Fel d1 and methods of use thereof
#621Soluble needle arrays for delivery of influenza vaccines
#622Aluminum compounds for use in therapeutics and vaccines
#623Combination heptavalent vaccine
#624Methods and compositions for intranasal delivery
#625Vaccines with live bacterial isolates for systemic administration
#626Prevention and treatment of sub-clinical PCVD
#627Vaccine composition
#628PCV/mycoplasma hyopneumoniae/PRRS combination vaccine
#629PCV/combination vaccine
#630vaccine
#631Compositions containing amino acids, phosphate and manganese and their uses
#632Influenza C virus and vaccine
#633Vaccine delivery method
#634Influenza hemagglutinin and neuraminidase variants
#635Personalized site-specific immunomodulation
#636Subunit vaccines for herpes viruses and methods of use
#637Method of preventing or treating influenza A viral infection using cloned DI influenza A viral particles
#638Biomarkers for prostate cancer and methods for their detection
#639Methods and compositions for intranasal delivery
#640Viral particles derived from an enveloped virus
#641Vaccine for enveloped viruses
#642Vaccines comprising cholesterol and CpG as sole adjuvant-carrier molecules
#643Nanoemulsion respiratory syncytial virus (RSV) subunit vaccine
#644Piscine reovirus immunogenic compositions
#645Universal vaccine against H5N1 lineages
#646DNA-PROTEIN VACCINATION PROTOCOLS
#647Composite body for antigen or drug delivery
#648COMPOSITION CONTAINING HCMV PARTICLES
#649VACCINE COMPRISING AN ATTENUATED PESTIVIRUS
#650NOVEL METHOD
#651Reverse genetics methods for virus rescue
#652COMPOSITION CONTAINING HCMV PARTICLES
#653Vaccine for chikungunya virus infection
#654Human respiratory syncytial virus vaccine
#655Disrupted adenovirus-based vaccine against drugs of abuse
#656Inactivating pathogens with oxidizing agents for vaccine production
#657Multi-phase emulsions based on amphiphilic block copolymers
#658Development of a marker foot and mouth disease virus vaccine candidate that is attenuated in the natural host
#659Chimeric Flavivirus Vaccines
#660Pneumovirus compositions and methods for using the same
#661USE OF NEWCASTLE DISEASE VIRUS-BASED VECTOR FOR INDUCING AN IMMUNE RESPONSE IN MAMMALS
#662Photo-Inactivated Viruses and Systems and Methods of Using the Same
#663Nanocarriers with multi-photon response elements
#664Methods and compositions for the treatment of influenza
#665Immunogenic anti-inflammatory compositions
#666HEPATITIS C VIRUS VACCINE COMPOSITION
#667Epinecidin-1 as a vaccine adjuvant for enhancing immune responses
#668Production of viral vaccines in suspension on avian embryonic derived stem cell lines
#669INACTIVATED POULTRY VACCINE
#670Vaccine Having a Peptide Adjuvant for Eliciting a Specific Immune Response to Treat Viral Infection and Other Conditions
#671Process for producing influenza vaccine
#672PROTECTION AGAINST PANDEMIC AND SEASONAL STRAINS OF INFLUENZA
#673Alphavirus replicon particles as immunological adjuvants
#674Methods of treating or preventing influenza associated illness with oxidative reductive potential water solutions
#675Vaccine composition
#676Vaccine stabilizer
#677Transcutaneous immunization without heterologous adjuvant
#678POLYANIONIC POLYMER ADJUVANTS FOR HAEMOPHILUS INFLUENZAE B SACCHARIDE VACCINES
#679Compositions and methods to treat and control tumors
#680MIXTURE OF NON-DIGESTIBLE OLIGOSACCHARIDES FOR STIMULATING THE IMMUNE SYSTEM
#681VACCINE FOR THE PREVENTION OF ACUTE LYMPHOBLASTIC LEUKEMIA
#682Methods for preparing vesicles and formulations produced therefrom
#683Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof
#684Vaccine
#685RSV F PROTEIN COMPOSITIONS AMD METHODS FOR MAKING SAME
#686Porcine circovirus type 2 (PCV2), immunogenic composition containing the same, test kit, and application thereof
#687Anti-RSV immunogens and methods of immunization
#688Adjuvant
#689Vaccine Compositions
#690NEUTRALIZING MOLECULES TO INFLUENZA VIRUSES
#691Method to enhance an immune response of nucleic acid vaccination
#692Human rotavirus vaccine strains and diagnostics
#693Recombinant attenuated dengue viruses comprising mutations in NS5 and the 3′ untranslated region
#694Recombinant hemagglutinin protein of influenza virus and vaccine containing the same
#695VIRAL VACCINE AND PROCESS FOR PREPARING THE SAME
#696COMPOSITION
#697Compositions and methods for modulating an immune response
#698MONOPARAMUNITY INDUCERS BASED ON ATTENUATED RABBIT MYXOMAVIRUSES
#699Tetravalent influenza vaccine and use thereof
#700Stable, spray dryed, immunogenic, viral compositions
#701VACCINE
#702Immunogenic compositions and uses thereof
#703Dry storage stabilizing composition for biological materials
#704Induction of an immune response against dengue virus using the prime-boost approach
#705Adjuvant-sparing multi-dose influenza vaccination regimen
#706Methods for one-dose intradermal delivery for non-live trivalent influenza vaccine
#707Circovirus sequences associated with piglet weight loss disease (PWD)
#708INACTIVATED VARICELLA ZOSTER VIRUS VACCINES, METHODS OF PRODUCTION, AND USES THEREOF
#709KITS FOR ONE-DOSE INTRADERMAL DELIVERY FOR NON-LIVE TRIVALENT INFLUENZA VACCINE
#710ADJUVANTED INFLUENZA VACCINES FOR PEDIATRIC USE
#711Cellular permissivity factor for viruses and uses thereof
#712MONOPARAMUNITY INDUCERS BASED ON ATTENUATED RABBIT MYXOMAVIRUSES
#713MONOPARAMUNITY INDUCERS BASED ON ATTENUATED RABBIT MYXOMAVIRUSES
#714Influenza hemagglutinin and neuraminidase variants
#715Circovirus sequences associated with piglet weight loss disease (PWD)
#716RECOMBINANT RACCOON POX VIRUS VACCINE AGAINST HIGHLY PATHOGENIC AVIAN INFLUENZA
#717Inactivated dengue virus vaccine with aluminium-free adjuvant
#718Materials and methods for respiratory disease control in canines
#719Reverse genetics of negative-strand RNA viruses in yeast
#720RECOMBINANT INACTIVATED VIRAL VECTOR VACCINE
#721RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME
#722Recombinant influenza vectors with tandem transcription units
#723High yield yellow fever virus strain with increased propagation in cells
#724Live attenuated chimeric porcine circovirus vaccine
#725Methods and compositions to generate and control the effector profile of T cells by simultaneous loading and activation of selected subsets of antigen presenting cells
#726CELL RECEPTOR BLOCKER FOR PREVENTING AND TREATING AVIAN INFLUENZA AND OTHER DISEASES CAUSED BY VIRUSES
#727METHODS FOR ISOLATING ENVELOPED VIRUS-BASED VLPS FREE OF INFECTIOUS AGENTS
#728DNA transfection system for the generation of negative strand RNA virus
#729Influenza vaccine
#730Bluetongue virus recombinant vaccines and uses thereof
#731FOOT AND MOUTH DISEASE VIRUS RECOMBINANT VACCINES AND USES THEREOF
#732dsRNAs as influenza virus vaccine adjuvants or immuno-stimulants
#733Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs
#734Method for Producing the Flu Virus
#735Inactivated chimeric vaccines and related methods of use
#736Vaccine Composition
#737Combination vaccine with acellular pertussis
#738Live attenuated virus vaccines for La Crosse virus and other Bunyaviridae
#739Tissue targeted antigenic activation of the immune response to treat cancers
#740Avian Influenza Virus Antigen, and Booster Immunization Method for Avian Influenza Vaccine in Combination with Mucosal Adjuvant Which is Effective Through Oral Administration
#741COMBINATION VACCINE WITH WHOLE CELL PERTUSSIS
#742Compositions Comprising Salmonella Porins and Uses Thereof as Adjuvants and Vaccines
#743PORCINE CIRCOVIRUS TYPE 2 AND USE THEREOF
#744Method for producing purified influenza virus antigen
#745Farnesoid-X-receptor antagonist as a vaccine adjuvant
#746Influenza hemagglutinin and neuraminidase variants
#747Prevention and treatment of sub-clinical PCVD
#748Immortal avian cell line and methods of use
#749COMPOSITIONS AND METHODS FOR TREATING HEPATITIS A
#750DNA PRIME/ACTIVATED VACCINE BOOST IMMUNIZATION TO INFLUENZA VIRUS
#751Immunogenic Influenza Composition
#752Stable, dried rotavirus vaccine, compositions and process for preparation thereof
#753Methods of immunizing pregnant heifers at three months of gestation
#754Astrovirus
#755Vaccines for inclusion body hepatitis
#756Rabies virus-based recombinant immunocontraceptive compositions and methods of use
#757West Nile Virus vaccine
#758SARS vaccine compositions and methods of making and using them
#759Avian reoviridae and vaccines thereof
#760INFLUENZA VACCINES
#761MULTIVALENT VACCINE AGAINST PORCINE TESCHOVIRUS AND OTHER DISEASE CAUSING ORGANISMS IN SWINE
#762Circovirus sequences associated with piglet weight loss disease (PWD)
#763Vaccine formulations comprising saponin-containing adjuvants
#764NOVEL USE
#765Infectious bursal disease virus antigenic isolates and vaccines
#766Microneedle device, and method for enhancing the efficacy of influenza vaccine by using microneedle device
#767HETERLOGOUS PRIME-BOOST IMMUNIZATION REGIMEN
#768INACTIVATED VIRUS COMPOSITIONS AND METHODS OF PREPARING SUCH COMPOSITIONS
#769Vaccine against varicella zoster virus
#770Inactivated Live-Attenuated Bluetongue Virus Vaccine
#771Treatment of pigs with PCV2 antigent
#772Stabilizing excipient for inactivated whole virus vaccine
#773COMPOSITION COMPRISING ISCOM PARTICLES AND LIVE MICRO-ORGANISMS
#774Method for using inactivated Japanese encephalitis virus particles as adjuvant
#775MUTATIONS IN THE INFLUENZA A VIRUS NS1 GENE AND USE THEREOF
#776Viral adjuvants
#777Methods of reducing virucidal activity in PCV-2 compositions and PCV-2 compositions with an improved immunogenicity
#778MULTI-PHASE EMULSIONS BASED ON AMPHIPHILIC BLOCK COPOLYMERS
#779Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus
#780ENHANCEMENT OF IMMUNOGENICITY OF ANTIGENS
#781VACCINE AGAINST VARICELLA ZOSTER VIRUS
#782Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof
#783RNA VIRUS VACCINES AND METHODS
#784Nucleic acid comprising chimeric gene derived from hepatitis C virus
#785Circovirus sequences associated with piglet weight loss disease (PWD)
#786Bluetongue virus vaccine and immunogenic compositions, methods of use and methods of producing same
#787Monoparamunity inducers based on attenuated rabbit myxoma viruses
#788Determination of antigenicity of an inactivated virus
#789Tissue targeted antigenic activation of the immune response to treat cancers
#790Method of producing japanese encephalitis vaccine stably storable over long time and use of the vaccine
#791PROCESS FOR TREATMENT OF RHEUMATOID ARTHRITIS, TREMORS/PARKINSON'S DISEASE, MULTIPLE SCLEROSIS AND NON-VIRAL BASED CANCERS
#792Identification of protective antigenic determinants of porcine reproductive and respiratory syndrome virus and uses thereof
#793Preparation of vaccines using photosensitizer and light
#794Methods of preparing myxomavirus compositions
#795Psoralen-inactivated viral vaccine and method of preparation
#796CHIMERIC FOOT AND MOUTH DISEASE VIRUSES
#797PREPARATION OF INFLUENZA VIRUS VACCINE ANTIGENS
#798HIV COMBINATION VACCINE AND PRIME BOOST
#799Human respiratory syncytial virus (RSV) vaccine
#800COMPOSITION CONTAINING HCMV PARTICLES
#801Alphavirus Vectors for Respiratory Pathogen Vaccines
#802IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF
#803PROCESS FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS, RHEUMATOID ARTHRITIS, TREMORS/PARKINSON'S DISEASE, MULTIPLE SCLEROSIS, NON-VIRAL BASED CANCERS, ALZHEIMERS'S DISEASE, MUSCULAR DYSTROPHY, ATTENTION DEFICIT DISORDER, ATTENTION DEFICIT HYPERACTIVITY DISORDER, COMPLEX REGIONAL PAIN SYNDROME, DIABETES, NEUROPATHIC PAIN, SPIDER ARTHRITIS, WEST NILE VIRUS, FIBROMYALGIA, SHINGLES, GOUT, MIGRAINE HEADACHES, SENILE DEMENTIA, POST POLIO SYNDROME, CENTRAL VIRUS DEAFNESS, ASTHMA, CHRONIC PAIN OF UNKNOWN ORIGIN AND HEPATITIS C
#804VIRAL VACCINE VECTORS
#805NANOEMULSION VACCINES
#806Monoparamunity inducers based on attenuated rabbit myxomaviruses
#807Polyinosinic acid-polycytidylic acid-based adjuvant
#808Respiratory syncytial virus with a genomic deficiency complemented in trans
#809Canine influenza virus and vaccine therefore
#810Cytomegalovirus vaccines and methods of production
#811Cellular permissivity factor for viruses and uses thereof
#812Vaccine for viruses that cause persistent or latent infections
#813Cattle reproductive disease vaccines
#814Macrocyclic lactone combination compositions, vaccines and methods for producing same
#815Influenza composition
#816Carrier Particle for a Microorganism or Subunit Thereof, Pharmaceutical Composition Comprising such Particles, Method for Preparation of this Composition and Its Use in the Treatment of Animals
#817Two-Step Temperature Profile for the Propagation of Viruses
#818Methods of Treating and Preventing Neurological Symptoms Caused by Avian Reovirus and Novel Associated Characteristics
#819Immunogenic Compositions and Methods for Treating and Preventing Animal Infections
#820Polyanionic polymer adjuvants for B saccharide vaccines
#821COMBINATION VACCINES WITH 1-HYDROXY-2-PHENOXYETHANE PRESERVATIVE
#822CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#823Method of Immunization Against the 4 Dengue Serotypes
#824NOVEL VACCINE COMPOSITION
#825Circovirus sequences associated with piglet weight loss disease (PWD)
#826CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#827CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#828Thermal inactivation of rotavirus
#829CIRCOVIRUS SEQUENCE ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#830Recoding method that removes inhibitory sequences and improves HIV gene expression
#831CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#832DELIVERY OF FLU ANTIBODIES TO SURFACES IN CONTACT WITH AIR
#833Adaptation of Pitman Moore strain of rabies virus to primary chick embryo fibroblast cell cultures
#834CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#835Circovirus sequences associated with piglet weight loss disease (PWD)
#836CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#837CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#838CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#839CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#840LOW-ADDITIVE INFLUENZA VACCINES
#841Vaccine Comprising an Oil in Water Emulsion Adjuvant
#842Attenuated recombinant newcastle disease virus and vaccine containing the same
#843CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#844CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#845Secretory IgA and IgG Antibody Inducer
#846MANUFACTURE OF BOOSTER VACCINES HAVING REDUCED ANTIGEN DOSES
#847Yeast-based therapeutic for chronic hepatitis C infection
#848COMPOSITIONS AND METHODS FOR CHITOSAN ENHANCED IMMUNE RESPONSE
#849Vaccines against influenza virus
#850Compositions and methods for increasing immunogenicity of glycoprotein vaccines
#851Chimeric pestiviruses
#852Enhancing efficacy of vaccines administered via the respiratory tract
#853Method and Device for Detecting Feline Immunodeficiency Virus
#854Methods for preventing and ameiliorating porcine respiratory and reproductive syndrome virus-associated disease by immunizing against porcine ttv infection
#855Methods of inducing TH-1 immune responses to HIV-1 by administering UV/psoralen-treated desialated inactiviated HIV-1 virions deficient in CD55 and CD59
#856Method to enhance an immune response of nucleic acid vaccination
#857PROCESS FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS, RHEUMATOID ARTHRITIS, TREMORS/PARKINSON'S DISEASE, MULTIPLE SCLEROSIS AND NON-VIRAL BASED CANCERS
#858Circovirus sequences associated with piglet weight loss disease (PWD)
#859VACCINE
#860Vaccine for porcine reproductive and respiratory syndrome, a preparion method and use thereof
#861Storage of Influenza Vaccines Without Refrigeration
#862NEW VACCINE FORMULATIONS
#863H3 equine influenza A virus
#864Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
#865IMMUNOLOGICAL COMPOSITION
#866Human rotavirus and vaccine composition comprising same
#867Inactivated FCV vaccines
#868Inactivated polio vaccines
#869Peptide adjuvant for influenza vaccination
#870Vaccine
#871Rabies vaccine
#872IPV-DPT vaccine
#873PRODUCTION OF BIOLOGICAL CARRIERS FOR INDUCTION OF IMMUNE RESPONSE AND INHIBITION OF VIRAL REPLICATION
#874MAKING INFLUENZA VIRUS VACCINES WITHOUT USING EGGS
#875Production of vaccines
#876Method of elicting or inducing an immune response
#877Adjuvant compositions
#878Neuraminidase-deficient live influenza vaccines
#879MUCOSAL IMMUNOGENIC SUBSTANCES COMPRISING A POLYINOSINIC ACID - POLYCYTIDILIC ACID BASED ADJUVANT
#880Nanoemulsion influenza vaccine
#881Influenza vaccine
#882Cell-derived viral vaccines with low levels of residual cell DNA
#883Inactivated influenza virus compositions
#884Inactivated nodavirus vaccine
#885FROZEN STOCKPILING OF INFLUENZA VACCINES
#886Methods for treating, preventing and diagnosing procine ttv infection
#887Recombinant attenuated dengue viruses comprising a deletion in the 3′ untranslated region and additional attenuating mutations induced by chemical mutagenesis
#888Enhancement of an immune response by administration of a cationic lipid-DNA complex (CLDC)
#889INFLUENZA VACCINE
#890Multi-subtype FIV vaccines
#891AVIAN VIRUS VACCINES AND USES THEREOF
#892Inactivated Chimeric Vaccines and Related Methods of Use
#893Viral vaccine composition, process and methods of use
#894VACCINE COMPRISING AN ATTENUATED PESTIVIRUS
#895Adjuvant-Sparing Multi-Dose Influenza Vaccination Regimen
#896Virus Vaccines Comprising Envelope-Bound Immunomodulatory Proteins and Methods of Use Thereof
#897Influenza vaccines extemporaneously adsorbed to aluminium adjuvants
#898ADENOVIRUS VACCINE UTILIZING IKK AS ADJUVANT
#899Cloned defective interfering influenza A virus
#900Circovirus sequences associated with piglet weight loss disease (PWD)